Fig. 2
From: Combination versus single-agent as palliative chemotherapy for gastric cancer
Overall survival according to the type of regimen (single vs. combination) in patients a < 70 years, b ≥ 70 years, and c after propensity score matching
Fig. 2 | BMC Cancer